FasterCures presents Partnering for Cures 2014



Be a part of medical research’s most forward-thinking, outcomes-oriented, and patient-focused event.

FasterCures, the Washington, DC-based center of the Milken Institute, will convene the sixth annual Partnering for Cures meeting Nov. 16-18 in New York. Partnering for Cures brings together leaders from all sectors in medical research with the express purpose of making collaboration happen – collaborations that must happen if we are to speed up the time it takes to turn discoveries into treatments and cures.

    • PARTICIPATE in solutions-focused dialogue about some of the most pressing challenges in medical research.
    • PARTNER with others who share your goals and could expand your strategies or advance your programs.
    • PRESENT your cross-sector, innovative initiative to potential partners and supporters.


  • Convene distinct sectors of the medical research enterprise to identify partnership opportunities that will advance outcomes‐driven medical research.
  • Catalyze a more effective and efficient medical research enterprise through more strategic and timely allocation of critical resources.
  • Cultivate cross-sector relationships that will lead to collaborative efforts necessary for the commercialization of new therapies.

Why do we need this meeting?

There is no other meeting of this scale convened for the sole purpose of forging strategic cross-sector collaborations that will:

  • facilitate industry partnerships that may lead to commercialization agreements;
  • empower philanthropists to make informed investment decisions and measure the return on their philanthropy;
  • provide direct access to disease experts with key insights on research trends and market needs;
  • enable medical research foundations to find the right partners and investors; and
  • engage academia to play an important role in driving some of the new business models accelerating the medical research and development process.

About FasterCures

FasterCures is not just our name – it’s our mission. FasterCures, a center of the Milken Institute, is an “action tank” that works to improve the medical research system – so that we can speed up the time it takes to get important new medicines from discovery to patients.

Be it lack of medical breakthroughs, limited resources, or restrictive policies that are stalling progress, patients are paying the price of delays in life or death consequences. More than 100 million Americans suffer from cancer, Alzheimer’s disease, diabetes, Parkinson’s disease, heart disease, and others for which there are still no cures – and, in many cases, few meaningful treatment options.

FasterCures’ mission is to accelerate the process of discovery and development of new medical solutions for deadly and debilitating diseases.

FasterCures works across all sectors and diseases to transform the way we pursue, fund, and conduct medical research. We are committed to:

  • fostering innovation and accountability across research organizations.
  • improving and continuously modernizing the medical research environment.
  • maximizing the development and use of research resources.

Learn more about our programs.

About the Milken Institute

The Milken Institute is an independent economic think tank whose mission is to improve the lives and economic conditions of diverse populations in the United States and around the world by helping business and public-policy leaders identify and implement innovative ideas for creating broad-based prosperity. The institute puts research to work with the goal of revitalizing regions and finding new ways to generate capital for people with original ideas. By creating ways to spread the benefits of human, financial, and social capital to as many people as possible – the democratization of capital – the Milken Institute hopes to contribute to prosperity and freedom in all corners of the globe. The institute is nonprofit, nonpartisan, and publicly supported.

Learn more at

2014 Agenda

Sun, 11/16

06:00 PM – 08:00 PM      Welcome Reception/ Registration


Mon, 11/17

06:30 AM – 06:00 PM      Registration

07:00 AM – 05:00 PM      Partnering

07:00 AM – 07:50 AM      Breakfast Roundtable Discussions

07:50 AM – 08:00 AM      Time=Lives Talk: Not if, when

08:00 AM – 09:00 AM      Plenary: The future of U.S. research leadership

09:15 AM – 10:10 AM       Playing nice in the sandbox: Can research-by-consortium accelerate progress against disease?

Pulling back the curtain on clinical trials data

Unlocking the mysteries of the human brain

10:15 AM – 10:40 AM      Brave Bosom: Free the Data

Solve ME/CFS Initiative: How to build your evidence base

Locemia Solutions, T1D Exchange, and The Helmsley Charitable Trust: Partnership for development of Dry-Mist Nasal Glucagon

10:45 AM – 11:10 AM      PROOF Centre and IO Informatics: ASK for PROOF (Applied Semantic Knowledgebases for Prevention of Organ Failure)

The Ontario Brain Institute: An integrated system of partnerships

Catalent Institute: Non-invasive Macromolecule Delivery Consortium

11:15 AM – 11:40 AM      The New York Stem Cell Foundation and Beyond Batten Disease Foundation: Multi-stakeholder collaboration to discover cures for juvenile Batten disease

Orion Bionetworks: Hacking brain disease for a cure

The NIH Centers for Accelerated Innovation

12:00 PM – 12:30 PM      Lunch

12:30 PM – 12:40 PM      Time=Lives Talk: The race to the starting line

12:40 PM – 01:40 PM      Plenary: The future of medical innovation: Beyond our wildest dreams?

01:55 PM – 02:50 PM      Entrepreneurs for Cures

02:55 PM – 03:20 PM      Structural Genomics Consortium and CHDI: Open access partnership for Huntington’s Disease research

CureDuchenne: Accelerating Access to Treatments of Duchenne Muscular Dystrophy

Medical Research Council Technology: MRCT Dementia Consortium – New models to accelerate novel medicines to patients

03:25 PM – 03:50 PM      The Hearing Restoration Project

Give To Cure

Medical Device Innovation Consortium

03:55 PM – 04:50 PM      Integrating PHD (personal health data) in medical R&D

Is disruptive innovation of clinical trials possible?

The power behind the ‘p’: PROs, patient preference, and patient-centered outcomes research

05:00 PM – 06:30 PM      Networking Reception

Tue, 11/18

06:30 AM – 01:00 PM      Registration

07:00 AM – 03:30 PM      Partnering

07:00 AM – 08:00 AM      Breakfast Roundtable Discussions

08:00 AM – 08:55 AM      The price of innovation: Who defines ‘value?’

The blurring boundary between the university and the marketplace

Democratizing science

09:00 AM – 09:25 AM      Focused Ultrasound Foundation: Blazing a trail for successful reimbursement of disruptive technologies

Indiana Clinical and Translational Science Institute: Strategic Pharma-Academic Research Consortium (SPARC) for Translational Medicine

HemoShear and Children’s National Health System: Rare Disease Drug Accelerator – A new paradigm to accelerate drug discovery for the treatment of rare diseases

09:30 AM – 09:55 AM      Mayo Clinic: Partnership to accelerate development of novel treatments for heart valve disease

ALD Connect

National Multiple Sclerosis Society: Multiple Sclerosis Outcome Assessments Consortium (MSOAC)

10:00 AM – 10:25 AM      Johns Hopkins University: The Neurofibromatosis Therapeutic Acceleration Program

Alzheimer’s Association: Amyloid Imaging Coverage with Evidence Development Workgroup

Seattle Children’s Research Institute and Kineta, Inc.: Alliance for Children’s Therapeutics

11:00 AM – 11:55 AM      Collaborative capital

(Re)defining impact: Assessing biomedical research investments

Man v. microbes: Can we win the war against antibiotic resistance?

12:15 PM – 12:45 PM      Lunch

12:45 PM – 12:55 PM      Time=Lives Talk: The business of fixing disease

12:55 PM – 01:55 PM      Plenary: Is the biopharma industry fit for the future?

02:10 PM – 02:35 PM      Addario Lung Cancer Medical Institute: Remote clinical trials – The genomics of young lung cancer study

University of California, San Francisco Clinical and Translational Science Institute and Quest: Dementia Program

Foundation for the National Institutes of Health: THE MAL-ED NETWORK – Sharing data and resources to gain a better understanding of child growth and development

02:40 PM – 03:05 PM      Patient-Centered Outcomes Research Institute: Engaging patients as partners to create PCORnet

Christopher & Dana Reeve Foundation: The Big Idea

Human Vaccines Project

03:20 PM – 03:30 PM      Time=Lives Talk: The perfect storm

03:30 PM – 04:30 PM      Plenary: Putting the patients in ‘patient-centeredness’

Click here more information 

Pricing Structure
General Attendees $1,800
Nonprofit, Government, and Academic Attendees * $550
Start-Up/Emerging Biotechs * $900